These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 3163773)
1. Clinical importance of near-diploid tumor stem lines in patients with osteosarcoma of an extremity. Look AT; Douglass EC; Meyer WH N Engl J Med; 1988 Jun; 318(24):1567-72. PubMed ID: 3163773 [TBL] [Abstract][Full Text] [Related]
2. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Jaffe N; Carrasco H; Raymond K; Ayala A; Eftekhari F Cancer; 2002 Nov; 95(10):2202-10. PubMed ID: 12412175 [TBL] [Abstract][Full Text] [Related]
4. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. Link MP; Goorin AM; Miser AW; Green AA; Pratt CB; Belasco JB; Pritchard J; Malpas JS; Baker AR; Kirkpatrick JA N Engl J Med; 1986 Jun; 314(25):1600-6. PubMed ID: 3520317 [TBL] [Abstract][Full Text] [Related]
5. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. Look AT; Hayes FA; Nitschke R; McWilliams NB; Green AA N Engl J Med; 1984 Jul; 311(4):231-5. PubMed ID: 6738617 [TBL] [Abstract][Full Text] [Related]
6. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701 [TBL] [Abstract][Full Text] [Related]
7. TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study. Wunder JS; Gokgoz N; Parkes R; Bull SB; Eskandarian S; Davis AM; Beauchamp CP; Conrad EU; Grimer RJ; Healey JH; Malkin D; Mangham DC; Rock MJ; Bell RS; Andrulis IL J Clin Oncol; 2005 Mar; 23(7):1483-90. PubMed ID: 15735124 [TBL] [Abstract][Full Text] [Related]
8. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous paired analysis of numerical chromosomal aberrations and DNA content in osteosarcoma. Serra M; Tarkkanen M; Baldini N; Scotlandi K; Sarti M; Maurici D; Manara MC; Benini S; Bacchini P; Knuutila S; Picci P Mod Pathol; 2001 Jul; 14(7):710-6. PubMed ID: 11455004 [TBL] [Abstract][Full Text] [Related]
10. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Bacci G; Longhi A; Cesari M; Versari M; Bertoni F Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623 [TBL] [Abstract][Full Text] [Related]
11. Relationship between histologic grade and cytofluorometric cellular DNA and RNA content in primary bone tumors. Takeshita H; Kusuzaki K; Kuzuhara A; Tsuji Y; Ashihara T; Gebhardt MC; Mankin HJ; Springfield DS; Hirasawa Y Anticancer Res; 2001; 21(2B):1271-7. PubMed ID: 11396198 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923 [TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapy. Baldini N; Scotlandi K; Serra M; Picci P; Bacci G; Sottili S; Campanacci M J Orthop Res; 1999 Sep; 17(5):629-32. PubMed ID: 10569469 [TBL] [Abstract][Full Text] [Related]
14. Post operative infection and increased survival in osteosarcoma patients: are they associated? Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803 [TBL] [Abstract][Full Text] [Related]
15. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502 [TBL] [Abstract][Full Text] [Related]
16. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas. Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594 [TBL] [Abstract][Full Text] [Related]
18. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients. Bacci G; Longhi A; Bertoni F; Briccoli A; Versari M; Pignotti E; Picci P Acta Orthop; 2006 Dec; 77(6):938-43. PubMed ID: 17260205 [TBL] [Abstract][Full Text] [Related]
19. DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients. Dreinhöfer KE; Baldetorp B; Akerman M; Fernö M; Rydholm A; Gustafson P Cytometry; 2002 Feb; 50(1):19-24. PubMed ID: 11857594 [TBL] [Abstract][Full Text] [Related]
20. CDH11 expression is associated with survival in patients with osteosarcoma. Nakajima G; Patino-Garcia A; Bruheim S; Xi Y; San Julian M; Lecanda F; Sierrasesumaga L; Müller C; Fodstad O; Ju J Cancer Genomics Proteomics; 2008; 5(1):37-42. PubMed ID: 18359978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]